USAID, Janssen Therapeutics Sign MOU To Support Efforts To Address MDR-TB

IIP Digital: More Nations to Receive Tuberculosis-Fighting Drug
“The U.S. Agency for International Development (USAID) signed a memorandum of understanding (MOU) with Janssen Therapeutics December 11 that aims to accelerate progress in the fight against antibiotic-resistant bacteria, specifically multidrug-resistant tuberculosis (MDR-TB). The intent of the MOU is for Janssen to donate $30 million worth of the drug SIRTURO® (bedaquiline) over a four-year period through USAID’s programs for the treatment of MDR-TB…” (12/15).